Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Karabou, Abdoulaye
Bisseux, Laurence
Pavese, Ida
Collon, Thierry
机构：
[1] Montfermeil Hosp, GHT Grand Paris Est, Med Oncol Unit, Montfermeil, France
[2] GHI LE Raincy Montfermeil, Montfermeil, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21585
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy of checkpoint inhibitors, tumor vaccines, and cellular immunotherapies in patients with advanced non-small cell lung cancer.
    Yu, Yunfang
    Ou, Qiyun
    Wang, Ying
    Liu, Zhifeng
    Fu, Tuping
    Gao, Quanlong
    Lin, Dagui
    Yao, Herui
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [32] Minority patients in clinical trials (CT) for advanced non-small cell lung cancer.
    Obasaju, CK
    Catalano, RB
    Marinucci, DM
    Bloss, JD
    Taylor, L
    Monberg, MJ
    Comis, RL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 658S - 658S
  • [33] Smoking affects treatment outcome in patients with advanced non-small cell lung cancer.
    Tsao, AS
    Liu, DD
    Lee, JJ
    Spitz, MR
    Hong, WK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 661S - 661S
  • [34] Access to specialist care and treatment in patients with advanced non-small cell lung cancer.
    Ganti, Apar Kishor
    Borghaei, Hossein
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Nivolumab timing as a major survival predictor in patients with stage IV non-small cell lung cancer.
    Karaboue, Abdoulaye
    Collon, Thierry
    Bodiguel, Viviane
    Cucherousset, Joel
    Innominato, Pasquale
    Bouchahda, Mohamed
    Adam, Rene
    Levi, Francis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Efficacy and safety of nivolumab for cytotoxic chemotherapy unfit patients with advanced non-small cell lung cancer: A phase II study
    Okuma, Y.
    Kitano, S.
    Watanabe, K.
    Yomota, M.
    Hosomi, Y.
    Zenke, Y.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Affordability of drug treatment in advanced non-small cell lung cancer.
    Chou, Yi-Ting
    Lafata, Jennifer Elston
    Farley, Joel
    Stinchcombe, Tom
    Proctor, Amber
    Dusetzina, Stacie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Alonso-Garcia, Miriam
    Sanchez-Gastaldo, Amparo
    Munoz-Fuentes, Miguel A.
    Molina-Pinelo, Sonia
    Boyero, Laura
    Benedetti, Johana Cristina
    Bernabe-Caro, Reyes
    PHARMACEUTICALS, 2022, 15 (05)
  • [39] Nivolumab for treating non-small cell lung cancer
    Guibert, Nicolas
    Mazieres, Julien
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1789 - 1797
  • [40] Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer
    Morgensztern, Daniel
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3713 - 3717
12345